BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28331340)

  • 1. Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors.
    Guo C; Chen X; Xiao W; Wang Q; Sun K; Wang Z
    Onco Targets Ther; 2017; 10():1465-1474. PubMed ID: 28331340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of diffusion-weighted magnetic resonance imaging in predicting World Health Organization grade in G1/G2 pancreatic neuroendocrine tumors.
    Guo C; Zhuge X; Chen X; Wang Z; Xiao W; Wang Q
    Oncol Lett; 2017 Jun; 13(6):4141-4146. PubMed ID: 28599415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic High-Grade Neuroendocrine Neoplasms in the Korean Population: A Multicenter Study.
    Kim H; An S; Lee K; Ahn S; Park DY; Kim JH; Kang DW; Kim MJ; Chang MS; Jung ES; Kim JM; Choi YJ; Jin SY; Chang HK; Cho MY; Kang YK; Kang M; Ahn S; Kim YW; Hong SM;
    Cancer Res Treat; 2020 Jan; 52(1):263-276. PubMed ID: 31319641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine liver metastases: Value of apparent diffusion coefficient and enhancement ratios for characterization of histopathologic grade.
    Besa C; Ward S; Cui Y; Jajamovich G; Kim M; Taouli B
    J Magn Reson Imaging; 2016 Dec; 44(6):1432-1441. PubMed ID: 27227756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging.
    Lotfalizadeh E; Ronot M; Wagner M; Cros J; Couvelard A; Vullierme MP; Allaham W; Hentic O; Ruzniewski P; Vilgrain V
    Eur Radiol; 2017 Apr; 27(4):1748-1759. PubMed ID: 27543074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of diffusion-weighted MR imaging in predicting the grade of nonfunctional pancreatic neuroendocrine tumors.
    Kulali F; Semiz-Oysu A; Demir M; Segmen-Yilmaz M; Bukte Y
    Diagn Interv Imaging; 2018 May; 99(5):301-309. PubMed ID: 29258825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?
    Toshima F; Inoue D; Komori T; Yoshida K; Yoneda N; Minami T; Matsui O; Ikeda H; Gabata T
    Jpn J Radiol; 2017 May; 35(5):242-253. PubMed ID: 28258323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
    Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
    Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic neuroendocrine tumors: correlation between histogram analysis of apparent diffusion coefficient maps and tumor grade.
    Pereira JA; Rosado E; Bali M; Metens T; Chao SL
    Abdom Imaging; 2015 Oct; 40(8):3122-8. PubMed ID: 26280127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of diffusion-weighted imaging mono-exponential mode with diffusion kurtosis imaging for predicting pathological grades of clear cell renal cell carcinoma.
    Cao J; Luo X; Zhou Z; Duan Y; Xiao L; Sun X; Shang Q; Gong X; Hou Z; Kong D; He B
    Eur J Radiol; 2020 Sep; 130():109195. PubMed ID: 32763475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grade 2 pancreatic neuroendocrine tumors: overbroad scope of Ki-67 index according to MRI features.
    Hu Y; Rao S; Xu X; Tang Y; Zeng M
    Abdom Radiol (NY); 2018 Nov; 43(11):3016-3024. PubMed ID: 29619528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of diffusion weighted imaging in combination with conventional MRI signs for inflammation activity of chronic hepatitis B].
    Ren HW; Ye HY; An WM; Dong JH; Liu Y
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(19):1484-1490. PubMed ID: 28535640
    [No Abstract]   [Full Text] [Related]  

  • 13. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
    Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS
    Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging.
    Zhu SC; Liu YH; Wei Y; Li LL; Dou SW; Sun TY; Shi DP
    World J Gastroenterol; 2018 Feb; 24(8):929-940. PubMed ID: 29491686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of the value of diffusion kurtosis imaging and diffusion-weighted imaging in evaluating the histological features of endometrial cancer.
    Yue W; Meng N; Wang J; Liu W; Wang X; Yan M; Han D; Cheng J
    Cancer Imaging; 2019 Feb; 19(1):9. PubMed ID: 30764876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage.
    De Robertis R; Cingarlini S; Tinazzi Martini P; Ortolani S; Butturini G; Landoni L; Regi P; Girelli R; Capelli P; Gobbo S; Tortora G; Scarpa A; Pederzoli P; D'Onofrio M
    World J Gastroenterol; 2017 Jan; 23(2):275-285. PubMed ID: 28127201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic neuroendocrine tumor: prediction of the tumor grade using magnetic resonance imaging findings and texture analysis with 3-T magnetic resonance.
    Guo CG; Ren S; Chen X; Wang QD; Xiao WB; Zhang JF; Duan SF; Wang ZQ
    Cancer Manag Res; 2019; 11():1933-1944. PubMed ID: 30881119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent diffusion coefficient on 3.0 Tesla magnetic resonance imaging and prognostic factors in breast cancer.
    De Felice C; Cipolla V; Guerrieri D; Santucci D; Musella A; Porfiri LM; Meggiorini ML
    Eur J Gynaecol Oncol; 2014; 35(4):408-14. PubMed ID: 25118482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
    Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T
    Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms.
    Pulvirenti A; Raj N; Cingarlini S; Pea A; Tang LH; Luchini C; Chou JF; Grego E; Marinova I; Capanu M; Landoni L; Scarpa A; Allen PJ; Klimstra DS; Reidy-Lagunes DL
    Pancreas; 2021 Feb; 50(2):138-146. PubMed ID: 33565789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.